| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 42,012 | 18,749 | ||
| Marketable securities | 53,808 | 15,175 | ||
| Accounts receivable, net | 52 | 83 | ||
| Inventory | 365 | 185 | ||
| Prepaid expenses and other current assets | 1,531 | 1,690 | ||
| Total current assets | 97,768 | 35,882 | ||
| Property and equipment, net | 1,595 | 1,366 | ||
| Right-of-use assets | 1,653 | 1,806 | ||
| Strategic investments | 2,495 | 2,495 | ||
| Deposits and other assets | 1,296 | 1,276 | ||
| Total assets | 104,807 | 42,825 | ||
| Accounts payable | 8,473 | 5,308 | ||
| Accrued expenses and other liabilities | 6,837 | 6,650 | ||
| Operating lease liability, current portion | 696 | 642 | ||
| Deferred revenue, current portion | 4,649 | 4,461 | ||
| Total current liabilities | 20,655 | 17,061 | ||
| Deferred revenue, less current portion | 8,659 | 9,568 | ||
| Royalty purchase agreement | 16,167 | - | ||
| Loan payable | 14,204 | 14,384 | ||
| Operating lease liability, less current portion | 1,135 | 1,328 | ||
| Other long-term liabilities | 248 | 189 | ||
| Total liabilities | 61,068 | 42,530 | ||
| Common stock, 0.0001 par value per share 340,000,000 shares authorized 56,464,731 and 38,194,442 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 6 | 4 | ||
| Additional paid-in capital | 412,512 | 348,271 | ||
| Accumulated other comprehensive income | 45 | 16 | ||
| Accumulated deficit | -368,824 | -347,996 | ||
| Total stockholders' equity | 43,739 | 295 | ||
| Total liabilities and stockholders' equity | 104,807 | 42,825 | ||
Orchestra BioMed Holdings, Inc. (OBIO)
Orchestra BioMed Holdings, Inc. (OBIO)